AnaptysBio, Inc.
ANAB
ISIN null / Valor 29675116
AnaptysBio, Inc.
UMushroom community rating:
About company
AnaptysBio, Inc. is a publicly traded, San Diego–based clinical-stage biotechnology company that discovers and develops antibody-based therapeutics primarily for inflammatory and immuno-oncology indications. The company uses a proprietary antibody discovery and optimization platform to generate monoclonal antibodies and antibody-derived candidates designed for specific functional profiles and reduced immunogenicity, advancing multiple programs through preclinical and clinical stages. AnaptysBio pursues development both independently and through strategic collaborations or licensing arrangements with larger pharmaceutical companies to support clinical development and potential commercialization.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
2532 M
Market cap (USD)
732,652
Daily traded volume (Shares)
/
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
